Literature DB >> 11469722

Induction of cytochromes P450.

E G Schuetz1.   

Abstract

Humans and rodents are exposed to many foreign compounds in their diet (e.g., herbal supplements such as St. John's wart), in their environment (e.g., organochlorine pesticides and polychorinated biphenyls), and as clinically prescribed drugs (e.g., rifampin and phenobarbital). In response to these exposures mammals have evolved mechanisms to induce proteins involved in xenobiotic detoxification. Metabolism by Phase I enzymes, particularly the heme containing monooxygenases cytochromes P450 is frequently the first line of defense against such xenobiotics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11469722     DOI: 10.2174/1389200013338595

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  12 in total

Review 1.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

Review 2.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

3.  The use of a high-throughput luminescent method to assess CYP3A enzyme induction in cultured rat hepatocytes.

Authors:  Martha C Garcia; Dongping Ma; A Thomas Dicioccio; James Cali
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-04-22       Impact factor: 2.416

4.  Role of cytochrome p450 isoenzymes 3A and 2D6 in the in vivo metabolism of mirabegron, a β3-adrenoceptor agonist.

Authors:  Jennifer Lee; Selina Moy; John Meijer; Walter Krauwinkel; Taiji Sawamoto; Virginie Kerbusch; Donna Kowalski; Michael Roy; Alan Marion; Shin Takusagawa; Marcel van Gelderen; James Keirns
Journal:  Clin Drug Investig       Date:  2013-06       Impact factor: 2.859

5.  Cytochrome P4503A: evidence for mRNA expression and catalytic activity in rat brain.

Authors:  Sanjay Yadav; Alok Dhawan; Prahlad K Seth; Ram L Singh; Devendra Parmar
Journal:  Mol Cell Biochem       Date:  2006-05-04       Impact factor: 3.396

6.  Determination of tumour hypoxia with the PET tracer [18F]EF3: improvement of the tumour-to-background ratio in a mouse tumour model.

Authors:  Nicolas Christian; Anne Bol; Marc De Bast; Daniel Labar; John Lee; Pierre Mahy; Vincent Grégoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03-03       Impact factor: 9.236

Review 7.  Functional evolution of the pregnane X receptor.

Authors:  Manisha Iyer; Erica J Reschly; Matthew D Krasowski
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-06       Impact factor: 4.481

8.  Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications.

Authors:  Matthew D Krasowski
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-11

9.  Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects.

Authors:  Nassr Nassr; Andreas Huennemeyer; Rolf Herzog; Oliver von Richter; Robert Hermann; Manuela Koch; Kevin Duffy; Karl Zech; Gezim Lahu
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

10.  Functional evolution of the vitamin D and pregnane X receptors.

Authors:  Erica J Reschly; Afonso Celso Dias Bainy; Jaco Joaquim Mattos; Lee R Hagey; Nathan Bahary; Sripal R Mada; Junhai Ou; Raman Venkataramanan; Matthew D Krasowski
Journal:  BMC Evol Biol       Date:  2007-11-12       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.